Skip to content

13F-HR filed by EcoR1 Capital, LLC

EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 71 holding rows worth $2,254,663,000.

Accession
0001567619-21-010348
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 71 entries on the cover page, a total value of $2,254,663,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,254,663,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock11,034,280$277,181,000thousands by filing date
XENCOR INC98401F105COMMON STOCK4,900,306$211,007,000thousands by filing date
MORPHIC HLDG INC61775R105COM2,999,315$189,797,000thousands by filing date
ANAPTYSBIO INC032724106COM7,151,624$154,117,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock13,247,017$138,431,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock3,429,363$118,553,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM2,533,635$110,542,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock3,692,637$104,391,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM464,298$79,534,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM3,092,218$75,759,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK2,458,259$71,879,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK2,019,019$62,771,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM2,195,892$61,661,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock9,202,702$50,891,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock2,103,950$45,887,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM1,224,175$39,786,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM3,122,704$38,440,000thousands by filing date
ATRECA INC04965G109COM2,426,685$37,201,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM1,137,940$34,024,000thousands by filing date
GRITSTONE BIO INC39868T105COM3,421,287$32,263,000thousands by filing date
AC IMMUNE SAH00263105SHS3,648,163$27,763,000thousands by filing date
AKOUOS INC00973J101COM1,975,984$27,407,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK6,082,200$24,450,000thousands by filing date
ARVINAS INC04335A105COM318,704$21,066,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM1,250,001$19,425,000thousands by filing date
ALECTOR INC014442107COMMON STOCK602,600$12,136,000thousands by filing date
ELEDON PHARMACEUTICALS INC28617k101COM1,115,721$11,938,000thousands by filing date
KRONOS BIO INC50107A104COM387,357$11,338,000thousands by filing date
APPLIED MOLECULAR TRANS INC03824M109COM239,443$10,538,000thousands by filing date
ALLOVIR INC019818103COM447,012$10,460,000thousands by filing date
NUVATION BIO INC67080N119WARR963,333$10,067,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock596,900$9,843,000thousands by filing date
BCTG ACQUISITION CORP05492W103COM800,000$8,896,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM260,000$8,887,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM741,290$7,858,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM1,000,000$7,480,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK200,000$7,398,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock556,354$6,587,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock250,000$6,280,000thousands by filing datecall
LOGICBIO THERAPEUTICS INC54142F102COM688,700$5,014,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM150,000$4,937,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN500,000$4,920,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM1,606,276$4,482,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS400,000$4,476,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM143,567$4,173,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM100,000$3,886,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock215,000$3,339,000thousands by filing date
VINCERX PHARMA INC92731L114*W EXP 12/24/202150,000$2,895,000thousands by filing date
AERPIO PHARMACEUTICALS INC00810B105COM2,072,782$2,674,000thousands by filing date
BIOATLA INC09077B104COM50,000$2,542,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN200,000$2,114,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM200,000$2,040,000thousands by filing date
FRAZIER LIFESCIENCES ACQU CORP UNIT EXP 120925G3710A121Stock200,000$2,032,000thousands by filing date
5 01 ACQUISITION CORP33836P105CMN200,000$1,998,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN200,000$1,996,000thousands by filing date
CONSONANCE HFW ACQUISITION CG2445M129UNIT 99/99/9999200,000$1,952,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM115,195$1,737,000thousands by filing date
PMV PHARMACEUTICALS INC69353Y103COM50,000$1,645,000thousands by filing date
ARYA SCIENCES ACQU CORP IVG31659108COM150,000$1,571,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM50,000$1,535,000thousands by filing date
PARDES BIOSCIENCES INC COM30318F100Stock150,000$1,494,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK94,819$1,368,000thousands by filing date
DEERFIELD HEALTHCARE TECH AC244413118*W EXP 07/16/202100,000$1,212,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN100,000$977,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM25,000$779,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/20266,666$665,000thousands by filing date
LIFESCI ACQUISITION II CORP53229E103COM56,500$573,000thousands by filing date
F-STAR THERAPEUTICS INC30315R107COM46,000$498,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A50,000$495,000thousands by filing date
METACRINE INC59101E103COM62,207$386,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS33,333$326,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-21-010348this filing2021-05-17acceptance time not in the bulk data set